Medical Practice Technical Challenges
Haematology
Multiple Myeloma and Other Monoclonal Gammopathies for Non-Haematologists
24-M46
June 21st 2024 - June 22nd 2024
COURSE COORDINATORS
Carlos Costa (MD) ,
Manuela Bernardo (MD)
COURSE PRESENTATION
Monoclonal gammopathies (MG) are highly prevalent haematological disorders that can lead to severe disease. As an age-associated disorder, and due to the easy access to diagnostic tests, the number of cases is expected to increase.
The current clinical tools allow for a very accurate assessment of prognosis, which may guide the best approach to each patient. As such, this course aims to provide a clear vision on how generalist physicians may provide the best guidance to a suspected MG, how clinical findings should be interpreted, which tests provide the most information, when to refer to a specialist and how to complement the specialist’s follow-up.
The current clinical tools allow for a very accurate assessment of prognosis, which may guide the best approach to each patient. As such, this course aims to provide a clear vision on how generalist physicians may provide the best guidance to a suspected MG, how clinical findings should be interpreted, which tests provide the most information, when to refer to a specialist and how to complement the specialist’s follow-up.
TARGET AUDIENCE
GP, internal medicine and other medical specialists
Clinical pathology doctors
Clinical pathology doctors
LEARNING OBJECTIVES >> KNOWLEDGE AND SKILLS TO DEVELOP
- Learn how to identify /search a monoclonal gammopathy
- Learn the symptoms or laboratory abnormalities that can lead to early diagnosis and specialist referral of patients with MM and other diseases with monoclonal gammopathy
- Learn the clinical factors that confer a dismal prognosis to the diseases
- Learn the sequelae of treatments and late effects in survivors
ADMISSION CRITERIA
CV
